Heart Rate Lowering With Ivabradine and Burden of Symptoms in Patients With Postural Orthostatic Tachycardia Syndrome

Le résumé fourni par la source

In the article “Heart Rate Lowering With Ivabradine and Burden of Symptoms in Patients With Postural Orthostatic Tachycardia Syndrome”,1 published in the July 2025 issue of the Journal of Cardiovascular Pharmacology, the authors wish to correct an error in Table 3. Specifically, the values for standing systolic blood pressure (SBP) and supine diastolic blood pressure (DBP) under the Ivabradine column were inadvertently inverted. The corrected values are: - SBP standing (mm Hg): 112 (98–132) - DBP supine (mm Hg): 62 (57–80) All associated statistics (change %, P-values) remain accurate. The corrected version of Table 3 is below. TABLE 3. - Changes in Heart Rate and Blood Pressure With Ivabradine Baseline Ivabradine Change % P HR supine (bpm) 80 (59–99) 65 (56–90) −9 (−20 to +2) 0.035 HR standing (bpm) 125 (93–135) 85 (68–100) −27 (−42 to −22) 0.008 ΔHR (bpm) 40 (30–70) 15 (8–19) −76 (−83 to −49) 0.011 SBP supine (mm Hg) 120 (100–134) 115 (105–129) −1 (−6 to +6) 0.779 SBP standing (mm Hg) 118 (98–127) 112 (98–132) +2 (−13 to +12) 0.953 DBP supine (mm Hg) 69 (60–86) 62 (57–80) −7 (−21 to +10) 0.286 DBP standing (mm Hg) 80 (64–89) 70 (65–88) −6 (−12 to +10) 0.476 Abbreviations: DBP, diastolic blood pressure; HR, heart rate; SBP, systolic blood pressure. The authors apologize for this oversight and confirm that it does not affect the conclusions of the article.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.